NAMI works with policymakers to advance priority issues and ensure that the voice of people affected by mental illness is considered in policymaking. Read NAMI’s recent letters to federal leaders, submitted comments and testimony and other resources.
NAMI is committed to ensuring accessibility for people with disabilities. If you would like to request an accessible version of any document on this page, please email us at mhpolicy@nami.org.
02/28/2025
Letter to HHS Secretary RFK Jr. to congratulate him on his confirmation, introduce the Mental Health Liaison Group, and encourage him to bring the voice of lived experience to the Make America Healthy Again (MAHA) Commission.01/29/2025
NAMI and Legal Action Center-led Mental Health Liaison Group coalition letter urging policymakers to protect Medicaid as a vital resource for mental health and substance use disorder care amid proposed federal policy changes to cut, cap, or alter Medicaid.12/20/2024
Regulatory comment to the Federal Communications Commission (FCC) on behalf of organizations in the Reimagine Crisis partnership, voicing support for the FCC’s proposed rule to implement georouting for texts to 988, so that text messages sent to the 988 Lifeline can be routed to the nearest call center.12/20/2024
Regulatory comment to the Federal Communications Commission (FCC) in response to proposed rules to implement georouting for texts to 988, so that text messages sent to the 988 Suicide and Crisis Lifeline can be routed to the nearest crisis call center.12/11/2024
Letter to the Indiana Governor Holcomb, on behalf of NAMI National, NAMI Indiana, Mental Health America, Mental Health America Indiana, Treatment Advocacy Center and Inseparable, requesting clemency for Joseph Corcoran.12/10/2024
Letter urging Congressional Budget Committees to protect Medicaid next year, including as part of any budget reconciliation process.11/21/2024
Letter encouraging Congress to support the funding level proposed by the Senate Appropriations Committee for two NIH programs, the BRAIN Initiative and the All of Us Research Program, which would continue to make revolutionary advances that can improve brain and overall health outcomes.11/18/2024
Letter from over 66 organizations representing behavioral health and criminal justice, to Senate and House leadership requesting that they pass the Reentry Act (H.R. 2400/S. 1165) and Due Process Continuity of Care Act (H.R. 3074/S. 971) by the end of the session.11/14/2024
Letter urging the Senate HELP and House Energy and Commerce Committees to include the bipartisan Kid Providing Resources for Optimal Outcomes Against Fatalities Act (Kid PROOF) in the reauthorization of the SUPPORT Act.11/12/2024
Regulatory comment to Secretary Becerra and Administrator Brooks-LaSure in support of the Notice of Benefit and Payment Parameters for 2026 Proposed Rule, and offering comments to strengthen the rule.11/04/2024
Regulatory comment encouraging FDA to remove barriers to care by allowing patients the choice to opt out of the Clozapine Risk Evaluation and Mitigation Strategy (REMS) after the initial highest risk period and to allow for emergency prescriptions when the administrative barriers are not met.10/31/2024
Letter to Congressional leadership urging the inclusion of the bipartisan Preventing Maternal Deaths Reauthorization Act in the final FY 2025 appropriations package or any other must-pass legislative package.NAMI HelpLine is available M-F, 10 a.m. – 10 p.m. ET. Call 800-950-6264,
text “helpline” to 62640, or chat online. In a crisis, call or text 988 (24/7).
